China Approves Phase III Trials Of Adimmune's Flu Vaccine
This article was originally published in PharmAsia News
Executive Summary
China has given Adimmune the go-ahead for Phase III trials of a low-cost vaccine to protect against influenza, with a launch possible as early as the first half of next year.